Yutaka Ishigai

Title: Yutaka Ishigai: Innovator in Angiogenesis Research

Introduction

Yutaka Ishigai is a prominent inventor based in Tokyo, Japan. He is known for his significant contributions to the field of angiogenesis research. His innovative work has led to the development of a unique compound that has potential therapeutic applications.

Latest Patents

Yutaka Ishigai holds 1 patent for a compound known as Thrombospondin 1-binding peptide. This compound promotes angiogenesis by inhibiting the function of TSP1, making it useful for the treatment or prophylaxis of diseases such as critical limb ischemia. The macrocyclic polypeptide he developed is represented by a specific formula that includes various amino acid residues, which contribute to its pharmacological properties.

Career Highlights

Throughout his career, Yutaka Ishigai has worked with notable companies, including Daiichi Sankyo Company, Limited and Peptidream Inc. His work in these organizations has allowed him to advance his research and contribute to the development of innovative therapeutic solutions.

Collaborations

Yutaka Ishigai has collaborated with esteemed colleagues such as Takahiro Yamaguchi and Yutaka Mori. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in the field of medicine.

Conclusion

Yutaka Ishigai's contributions to angiogenesis research and his innovative patent demonstrate his commitment to advancing medical science. His work has the potential to significantly impact the treatment of critical diseases, showcasing the importance of innovation in healthcare.